A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line-Reference-Cited by-同舟云学术

A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line

Published:2018-03-09 Issue:sup2 Volume:46 Page:1-8
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Abdollahpour-Alitappeh Meghdad¹²,Hashemi Karouei Seyed Masoud³,Lotfinia Majid⁴,Amanzadeh Amir²,Habibi-Anbouhi Mahdi²

Affiliation:

1. Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran;

2. National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran;

3. Department of Biology, Babol Branch Islamic Azad University, Babol, Iran;

4. Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Funder

Pasteur Institute of Iran

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2018.1449119

Reference39 articles.

1. Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma

2. Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

3. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and preclinical advances in PSMA-Directed Antibody-Drug conjugates (ADCs): Current status and hope for the future;Bioorganic Chemistry;2024-12

2. Advances in immunotoxin engineering: precision therapeutic strategies in modern oncology;Medical Oncology;2024-09-04

3. Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence;Life Sciences;2024-09

4. Antibody-drug conjugates: Principles and opportunities;Life Sciences;2024-06

5. Antibody–Antibiotic Conjugates: A Comprehensive Review on Their Therapeutic Potentials Against BacterialInfections;Journal of Clinical Laboratory Analysis;2024-05